Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illinois Tool Works Inc. (ITW) vs Medpace Holdings Inc (MEDP) Price & Performance

Illinois Tool Works Inc.Trade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Illinois Tool Works Inc. vs Medpace Holdings Inc — how do they compare? Illinois Tool Works Inc. trades at $292.19 (market cap $83.49B), while Medpace Holdings Inc trades at $601.56 (market cap $16.90B). The key difference: Illinois Tool Works Inc. is far larger — about 4.9× Medpace Holdings Inc's market cap, and Illinois Tool Works Inc. pays a 2.35% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

ITWMEDP
Market Cap
$83.49B$16.90B
Sector
IndustrialsTechnology
52-Week High
$299.60$620.59
52-Week Low
$241.07$393.42
Enterprise Value
$92.34B$16.52B
Dividend Yield
2.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illinois Tool Works Inc.

ITW trades at $294.52, down 0.72% today, with bullish technical signals from moving averages and a consensus price target of $314.25 representing 6.7% upside. The company has beaten earnings estimates for three consecutive quarters, maintains strong profitability with 19.39% net margins, and recently announced a 7% dividend increase alongside a $6 billion share repurchase program. Revenue remains stable around $16 billion annually with consistent cash flow generation.

The outlook remains positive given strong operational execution and shareholder returns, though valuation multiples appear elevated with a P/E of 26.55. Key risks include potential margin pressure from economic cycles and high debt levels at 55.54% of assets. The stock offers quality exposure to industrial recovery with disciplined capital allocation.

Medpace Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Illinois Tool Works Inc.

Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.

Read more on ITW

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP